A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.

Also called NCT02152280

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 320 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02152280
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02152280. Randomized; double masking; primary purpose treatment. Start 2014-03 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial of Danhong Injection in Treating Acute Ischemic Stroke
Condition
Stroke
Intervention (Drug)
Danhong Injection
Intervention (Drug)
Normal Saline
Lead sponsor
Beijing Bozhiyin T&S Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02152280
Content hash
bcebce811b7b4b6ee09a44a38b2d92f778d34545668a3c79f31d59c383271245